HCA Healthcare (NYSE:HCA) Price Target Cut to $390.00 by Analysts at Truist Financial

HCA Healthcare (NYSE:HCA - Get Free Report) had its price target cut by Truist Financial from $430.00 to $390.00 in a research note issued on Monday,Benzinga reports. The firm currently has a "buy" rating on the stock. Truist Financial's target price would suggest a potential upside of 31.56% from the company's previous close.

Several other research analysts also recently commented on the stock. KeyCorp cut their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating for the company in a report on Monday, October 28th. Oppenheimer boosted their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an "outperform" rating in a research note on Monday, October 28th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Wells Fargo & Company lowered shares of HCA Healthcare from an "equal weight" rating to an "underweight" rating and cut their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Finally, Morgan Stanley cut their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a report on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $388.60.

HCA Healthcare Stock Performance

HCA traded down $0.25 during trading hours on Monday, hitting $296.45. The stock had a trading volume of 1,440,887 shares, compared to its average volume of 1,221,162. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock has a market cap of $75.09 billion, a PE ratio of 13.31, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64. HCA Healthcare has a 1 year low of $276.50 and a 1 year high of $417.14. The company's fifty day simple moving average is $326.93 and its 200 day simple moving average is $354.99.

Insider Activity

In related news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company's stock, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the firm's stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

Institutional Trading of HCA Healthcare

Several large investors have recently added to or reduced their stakes in HCA. Oliver Luxxe Assets LLC increased its position in shares of HCA Healthcare by 2.9% during the fourth quarter. Oliver Luxxe Assets LLC now owns 12,284 shares of the company's stock valued at $3,687,000 after buying an additional 344 shares during the period. Fortem Financial Group LLC raised its position in shares of HCA Healthcare by 2.8% in the 4th quarter. Fortem Financial Group LLC now owns 4,263 shares of the company's stock worth $1,280,000 after acquiring an additional 115 shares in the last quarter. Nordea Investment Management AB boosted its position in shares of HCA Healthcare by 29.7% during the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company's stock valued at $253,020,000 after purchasing an additional 193,075 shares in the last quarter. Centre Asset Management LLC raised its holdings in HCA Healthcare by 6.4% in the fourth quarter. Centre Asset Management LLC now owns 4,555 shares of the company's stock worth $1,367,000 after purchasing an additional 274 shares in the last quarter. Finally, Modus Advisors LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $85,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.